Avidicure
Develops AVC-Boosters to enhance NK cells, activate the immune system, and provide broad anti-tumor responses for cancer immunotherapy.
Employees
Enterprise value
$193—290m
Related Content
Analytics
Unlock the full power of analytics with a premium account
Track company size and historic growth
Track team composition and strength
Track website visits and app downloads